Zhitong Finance App News, Gushengtang (02273) announced that on August 27, 2026, the company's subsidiary Gushengtang Malaysia Sdn. Bhd. (“Gushengtang Malaysia”) with YC TCM (Taman Segar) Sdn. Bhd. (“YC TCM SEGAR”), YC TCM Sdn. Bhd. (“YC TCM”) and SWS Medical Sdn. Bhd. The shareholders (“Seller”) of (“SWS Medical”) enter into a sales contract. Gushengtang Malaysia agreed to buy and the seller agreed to sell 100% of YC TCM SEGAR, YC TCM and SWS Medical.

YC TCM SEGAR, YC TCM, and SWS Medical are all medical institutions that mainly provide traditional Chinese medicine consultation = consultation and treatment services in Malaysia.

The acquisition is in line with the Group's expansion strategy to expand its network of offline medical institutions through acquisitions, provided that the company believes that the acquisition will (i) increase the company's market share in Malaysia; and (ii) create synergy between YC TCM SEGAR, YC TCM and SWS Medical with the Group's other offline medical institutions and online medical platforms.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.